共 17 条
[1]
Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Phillips NR,Waters D,Havel RJ. Circulation . 1993
[2]
Atherosclerosis and arterial influx of lipoproteins. Nordestgaard BG,Nielsen LB. Current Opinion in Lipidology . 1994
[3]
Triglyceride and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Hodis HN,Mack WJ,Azen SP,et al. Circulation . 1994
[4]
Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorbtion from human atherosclerotic plaque. Rapp JH,Lespine A,Hamilton RJ,et al. Arteriosclerosis and Thrombosis . 1994
[5]
The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. Santamarina-Fojo S,Haudenschild C,Amar M. Current Opinion in Lipidology . 1998
[6]
Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). West of Scotland Coronary Prevention Study Group. Circulation . 1998
[7]
Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients. Ericsson CG,Hamsten A,Nilsson J,et al. The Lancet . 1996
[8]
Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS).Treatment effects and relation to coronary angiographic progression. Mack WJ,Krauss RM,Hodis HN. Arteriosclerosis and Thrombosis . 1996
[9]
Heterogeneity of apolipoprotein B-100-containing lipoproteins: what we have learnt from kinetic studies. Millar JS,Packard CJ. Current Opinion in Lipidology . 1998
[10]
Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Sattar N,Bendomir A,Berry C,et al. Obstetrics and Gynecology . 1997